Sustained T Cell Immunity, Protection and Boosting Using Extended Dosing Intervals of BNT162b2 mRNA Vaccine (2021)
Attributed to:
Phase 1 COVID-19 Immunity - National Core Study
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.2139/ssrn.3891065
Publication URI: http://dx.doi.org/10.2139/ssrn.3891065
Type: Journal Article/Review
Parent Publication: SSRN Electronic Journal